Is there a useful cash-price range?
As of September 2026, maker cash offers for certain weight and diabetes drugs mostly fell between $149 and $499 per month.
These prices included products containing semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), among others.
The price depends on the exact product, the amount of medicine in each dose and whether a starting discount applies. Some discounts also require the next purchase within a set time after the last delivery. Miss that deadline and the medicine can cost more, even if your dose stays the same.
These prices pay for the medicine only. Ask separately about the care fee. Check how many days or how much medicine the advertised “month” includes.
Does paying cash count toward my plan’s limit?
The deductible is what you must pay before certain benefits under your plan begin. The yearly out-of-pocket maximum limits your share of covered bills that meet the plan’s rules. It does not limit every bill you might pay.
As of September 2026, buying through these makers’ cash offers means paying outside insurance. Those payments do not count toward your deductible or yearly maximum; they are extra. Ask your plan to list which charges count.
Will this offer last?
As of September 2026, many maker offers and savings cards listed an end date of December 31, 2026.
That is a date to recheck the terms, not a promise about the next price.
Ask for the price after the starting discount and what you must do to keep that price.